<HTML>
<HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV
style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">
<DIV style="font-size: 10pt">
<DIV
style="font-size: 1pt; width: 100%; border-bottom: black 2pt solid">&nbsp;</DIV>
<DIV
style="font-size: 1pt; width: 100%; border-bottom: black 1pt solid">&nbsp;</DIV>

<P style="font-size: 14pt" align="center"><B>UNITED STATES<BR>
SECURITIES AND
EXCHANGE COMMISSION<BR>
<FONT style="font-size: 12pt">Washington, D.C. 20549
</FONT></B>

<P style="font-size: 18pt" align="center"><B>FORM 8-K</B>

<P style="font-size: 12pt" align="center"><B>CURRENT REPORT<BR>
Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934</B>

<P style="font-size: 10pt" align="center"><B>Date of Report (Date of earliest
event reported): April 1, 2009</B>

<P style="font-size: 24pt" align="center"><B>VALIANT HEALTHCARE,
INC.<BR>
</B><FONT style="font-size: 10pt">(Exact name of registrant as
specified in its charter) </FONT>
<TABLE style="font-size: 10pt; text-align: center" cellspacing="0"
cellpadding="0" width="100%" border="0">

 <TR>
  <TD width="32%">&nbsp;</TD>
  <TD width="1%">&nbsp;</TD>
  <TD width="33%">&nbsp;</TD>
  <TD width="1%">&nbsp;</TD>
  <TD width="32%">&nbsp;</TD>
 </TR>
 <TR valign="bottom">
  <TD style="border-bottom: #000000 1px solid"><B>Delaware</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid"><B>000-53487</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid"><B>26-2871644</B></TD>
 </TR>
 <TR valign="top">
  <TD>(State or other Jurisdiction of Incorporation)</TD>
  <TD>&nbsp;</TD>
  <TD>(Commission File Number)</TD>
  <TD>&nbsp;</TD>
  <TD>(IRS Employer Identification No.)</TD>
 </TR>

</TABLE>
<TABLE style="font-size: 10pt; text-align: center" cellspacing="0"
cellpadding="0" width="100%" border="0">

 <TR>
  <TD width="49%">&nbsp;</TD>
  <TD width="1%">&nbsp;</TD>
  <TD width="49%">&nbsp;</TD>
 </TR>
 <TR valign="bottom">
  <TD style="border-bottom: #000000 1px solid"><B>210 N. University Drive,
Suite 810, Coral Springs, Florida</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid"><B>33071</B></TD>
 </TR>
 <TR valign="top">
  <TD>(Address of Principal Executive Offices)</TD>
  <TD>&nbsp;</TD>
  <TD>(Zip Code)</TD>
 </TR>

</TABLE>


<P style="font-size: 10pt" align="center">Registrant&#8217;s telephone number,
including area code: <B>(954) 419-1835</B>
<TABLE style="font-size: 10pt; text-align: center" cellspacing="0"
cellpadding="0" width="30%" border="0">

 <TR>
  <TD width="100%">&nbsp;</TD>
 </TR>
 <TR>
  <TD style="border-bottom: #000000 1px solid" nowrap><B>N/A<BR>
</B></TD>
 </TR>
 <TR>
  <TD nowrap>(Former name or former address if changed since last report.)</TD>
 </TR>

</TABLE>


<P style="font-size: 10pt" align="left">Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:

<P style="font-size: 10pt" align="left"><FONT face="Wingdings">o</FONT> Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)<BR>
<BR>
<FONT face="Wingdings">o</FONT> Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)<BR>
<BR>
<FONT
face="Wingdings">o</FONT> Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))<BR>
<BR>
<FONT
face="Wingdings">o</FONT> Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))<BR>


<DIV
style="margin-top: 10pt; font-size: 1pt; width: 100%; border-bottom: black 1pt solid">&nbsp;</DIV>
<DIV
style="font-size: 1pt; width: 100%; border-bottom: black 2pt solid">&nbsp;</DIV>
</DIV>

<P style="font-size: 10pt" align="center">&nbsp;

<P style="display: none; font-size: 10pt" align="center">1
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">

<P style="font-size: 10pt" align="justify"><U><B>Item&nbsp;2.01
</B></U><B>&#8211; </B><U><B>Completion of Acquisition or Disposition of
Assets</B></U>.

<P style="font-size: 10pt; text-indent: 4%" align="justify">On April&nbsp;1,
2009, Valiant Healthcare, Inc. completed the acquisition of substantially all
of the home health care assets of Accessible Healthcare Services, Inc., a
Florida corporation, through the execution of an Asset Purchase Agreement (the
&#8220;Agreement&#8221;). A copy of the Agreement is filed herewith as
Exhibit&nbsp;2.1 to this Current Report on Form 8-K and is incorporated herein
by reference.

<P style="font-size: 10pt; text-indent: 4%" align="justify">At the time of the
completion of the Agreement, the sole officer and director of Valiant was also
an officer in Accessible and the sole stockholder of Valiant was also a
significant stockholder and director of Accessible.

<P style="font-size: 10pt; text-indent: 4%" align="justify">The purchase price
for the assets of Accessible consisted solely of 10,950,000 shares of the
common stock of Valiant. Accessible was in the business of offering and selling
franchises for the operation of a home health care (medical and non-medical)
business under the name Accessible Home Health Care.

<P style="font-size: 10pt" align="justify"><U><B>Item&nbsp;3.02
</B></U><B>&#8211; </B><U><B>Unregistered Sales of Equity Securities</B></U>.

<P style="font-size: 10pt; text-indent: 4%" align="justify">As stated above in
Item&nbsp;2.01, all of the purchase price for this acquisition consisted of
10,950,000 shares of common stock of Valiant. Valiant relied upon the exemption
provided by Section&nbsp;4(2) of the Securities Act of 1933, as amended and
Rule&nbsp;506 of Regulation&nbsp;D.

<P style="font-size: 10pt" align="justify"><U><B>Item&nbsp;5.02 </B></U><B>&#8211; </B><U><B>Departures of Directors or Certain Officers;
Election of Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers</B></U>.

<P style="font-size: 10pt; text-indent: 4%" align="justify">Valiant&#8217;s
Board of Directors determined that certain of the prior officers of
Accessible should continue in office as officers of Valiant. Therefore, pursuant
to Article IV of the Valiant&#8217;s Bylaws, the following
individuals are appointed to the office designated below to serve
until the next annual meeting of the Board of Directors and until
their successors have been elected and qualified:

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="4%">&nbsp;</TD>
    <TD width="36%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="55%">&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD>&nbsp;</TD>
    <TD valign="top">Steven Turner</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">President</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD>&nbsp;</TD>
    <TD valign="top">John Rowsell</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Senior Vice President of Franchise
Relations</TD>
</TR>
<TR valign="bottom" style="background: #cceeff; padding-top: 1px">
    <TD>&nbsp;</TD>
    <TD valign="top">Gregory L. Greenland</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Senior Vice President of Corporate
Development</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD>&nbsp;</TD>
    <TD valign="top">John T. Titus</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Vice President of Finance</TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>


<P style="font-size: 10pt; text-indent: 4%" align="justify">Valiant&#8217;s
Board of Directors increased the size of the Board from one to eight members,
effective April&nbsp;2, 2009. To fill the vacancies created by the increase in
the size of the Board, the following individuals were appointed to serve until
the next annual meeting of Valiant&#8217;s stockholders or until their
successor has been elected and qualified: Cheryl Rager, Mirella Salem, Boris Bergus, Ron E.
Katz, Marc Love, John J. McAteer and Barry I. Rubin. There are no arrangements
or understandings between any of the new directors and any other persons,
pursuant to which such director was selected as a director.

<P style="font-size: 10pt; text-indent: 4%" align="justify">Valiant is in the
process of organizing its new Board and will disclose the formation of and
membership on any Board committees at that time.

<P style="font-size: 10pt" align="justify"><U><B>Item&nbsp;5.06 </B></U><B>&#8211; </B><U><B>Change in Shell Company Status</B></U>.

<P style="font-size: 10pt; text-indent: 4%" align="justify">After the
transaction described in Item&nbsp;2.01 herein, Valiant shall no longer be
considered a shell company, as such term is defined in Rule&nbsp;12b-2 under
the Securities Exchange Act of 1934, as amended. The material terms of the
transaction are described in Item&nbsp;2.01 herein.

<P style="font-size: 10pt" align="center">2

<P style="font-size: 10pt" align="center">&nbsp;

<P style="display: none; font-size: 10pt" align="center">2
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">

<P style="font-size: 10pt" align="justify"><U><B>Item&nbsp;8.01
</B></U><B>&#8211; </B><U><B>Other Events</B></U>.

<P style="font-size: 10pt; text-indent: 4%" align="justify">On April&nbsp;1,
2009, Valiant&#8217;s Board and stockholders approved the adoption of
Valiant&#8217;s 2009 Stock Incentive Plan, a copy of which is filed with this
Form 8-K as Exhibit&nbsp;8.1. Valiant has reserved up to 12,000,000 shares of
its common stock to issue under grants as part of this plan.

<P style="font-size: 10pt" align="justify"><U><B>Item&nbsp;9.01
</B></U><B>&#8211; </B><U><B>Financial Statements and Exhibits</B></U>.

<P style="font-size: 10pt" align="justify">(a)&nbsp;Financial statements of
business acquired.

<P style="font-size: 10pt; text-indent: 4%" align="justify">If required,
financial statements will be filed by amendment to this Form 8-K within
71&nbsp;days from the date that the filing of this report is required.

<P style="font-size: 10pt" align="justify">(b)&nbsp;Pro forma financial
information.

<P style="font-size: 10pt; text-indent: 4%" align="justify">If required, pro
forma financial information will be filed by amendment to this Form 8-K within
71&nbsp;days from the date that the filing of this report is required.

<P style="font-size: 10pt" align="justify">(c)&nbsp;Exhibits. The following
exhibits are filed with this Report:

<P style="font-size: 10pt; margin-left: 4%" align="justify">2.1 &#8211; Asset
Purchase Agreement, dated April&nbsp;1, 2009, by and between Valiant
Healthcare, Inc. and Accessible Healthcare Services, Inc.

<P style="font-size: 10pt; margin-left: 4%" align="justify">8.1 &#8211; Valiant
Healthcare, Inc. 2009 Stock Incentive Plan

<P style="font-size: 10pt" align="center"><B>SIGNATURES</B>

<P style="font-size: 10pt; text-indent: 4%" align="justify">Pursuant to the
requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this Current Report on Form 8-K to be signed on its behalf by the
undersigned hereunto duly authorized.

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" cellpadding="0" width="100%" border="0">
<!-- Begin Table Head -->

<TR valign="bottom">
  <TD width="48%">&nbsp;</TD>
  <TD width="4%">&nbsp;</TD>
  <TD width="48%">&nbsp;</TD>
</TR>
<!-- End Table Head -->

<!-- Begin Table Body -->

 <TR valign="bottom">
  <TD>&nbsp;</TD>
  <TD valign="top" align="left" colspan="2">VALIANT HEALTHCARE, INC.</TD>
 </TR>


<TR><TD>&nbsp;</TD></TR>

 <TR valign="bottom">
  <TD>&nbsp;</TD>
  <TD valign="top" align="left">By:</TD>
  <TD valign="top" align="left" style="border-bottom: #000000 1px solid"><I>/s/ Steven Turner</I></TD>
 </TR>

 <TR valign="bottom">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left">Name: Steven Turner<BR>
Title: President</TD>
 </TR>
<!-- End Table Body -->

</TABLE>
</DIV>

<P style="font-size: 10pt" align="justify">Dated: April&nbsp;1, 2009

<P style="font-size: 10pt" align="center">3

<P style="font-size: 10pt" align="center">&nbsp;

<P style="display: none; font-size: 10pt" align="center">3
</DIV>
</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "c83354e8vk.htm", "description": "FORM 8-K", "secsgml_size_bytes": 12679}]
{"company-data": {"conformed-name": "Valiant Healthcare, Inc.", "cik": "0001449491", "assigned-sic": "6770", "irs-number": "262871644", "state-of-incorporation": "DE", "fiscal-year-end": "0630"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-53487", "film-number": "09725620"}, "business-address": {"street1": "210 NORTH UNIVERSITY DRIVE", "street2": "SUITE 810", "city": "CORAL SPRINGS", "state": "FL", "zip": "33071", "phone": "954-419-1835"}, "mail-address": {"street1": "210 NORTH UNIVERSITY DRIVE", "street2": "SUITE 810", "city": "CORAL SPRINGS", "state": "FL", "zip": "33071"}}
Form 8-K
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest
event reported): April 1, 2009
VALIANT HEALTHCARE,
INC.
(Exact name of registrant as
specified in its charter)
Delaware
000-53487
26-2871644
(State or other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
210 N. University Drive,
Suite 810, Coral Springs, Florida
33071
(Address of Principal Executive Offices)
(Zip Code)
Registrant's telephone number,
including area code:
(954) 419-1835
N/A
(Former name or former address if changed since last report.)
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:
o
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.01
–
Completion of Acquisition or Disposition of
Assets
.
On April 1,
2009, Valiant Healthcare, Inc. completed the acquisition of substantially all
of the home health care assets of Accessible Healthcare Services, Inc., a
Florida corporation, through the execution of an Asset Purchase Agreement (the
"Agreement"). A copy of the Agreement is filed herewith as
Exhibit 2.1 to this Current Report on Form 8-K and is incorporated herein
by reference.
At the time of the
completion of the Agreement, the sole officer and director of Valiant was also
an officer in Accessible and the sole stockholder of Valiant was also a
significant stockholder and director of Accessible.
The purchase price
for the assets of Accessible consisted solely of 10,950,000 shares of the
common stock of Valiant. Accessible was in the business of offering and selling
franchises for the operation of a home health care (medical and non-medical)
business under the name Accessible Home Health Care.
Item 3.02
–
Unregistered Sales of Equity Securities
.
As stated above in
Item 2.01, all of the purchase price for this acquisition consisted of
10,950,000 shares of common stock of Valiant. Valiant relied upon the exemption
provided by Section 4(2) of the Securities Act of 1933, as amended and
Rule 506 of Regulation D.
Item 5.02
–
Departures of Directors or Certain Officers;
Election of Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers
.
Valiant's
Board of Directors determined that certain of the prior officers of
Accessible should continue in office as officers of Valiant. Therefore, pursuant
to Article IV of the Valiant's Bylaws, the following
individuals are appointed to the office designated below to serve
until the next annual meeting of the Board of Directors and until
their successors have been elected and qualified:
Steven Turner
President
John Rowsell
Senior Vice President of Franchise
Relations
Gregory L. Greenland
Senior Vice President of Corporate
Development
John T. Titus
Vice President of Finance
Valiant's
Board of Directors increased the size of the Board from one to eight members,
effective April 2, 2009. To fill the vacancies created by the increase in
the size of the Board, the following individuals were appointed to serve until
the next annual meeting of Valiant's stockholders or until their
successor has been elected and qualified: Cheryl Rager, Mirella Salem, Boris Bergus, Ron E.
Katz, Marc Love, John J. McAteer and Barry I. Rubin. There are no arrangements
or understandings between any of the new directors and any other persons,
pursuant to which such director was selected as a director.
Valiant is in the
process of organizing its new Board and will disclose the formation of and
membership on any Board committees at that time.
Item 5.06
–
Change in Shell Company Status
.
After the
transaction described in Item 2.01 herein, Valiant shall no longer be
considered a shell company, as such term is defined in Rule 12b-2 under
the Securities Exchange Act of 1934, as amended. The material terms of the
transaction are described in Item 2.01 herein.
2
Item 8.01
–
Other Events
.
On April 1,
2009, Valiant's Board and stockholders approved the adoption of
Valiant's 2009 Stock Incentive Plan, a copy of which is filed with this
Form 8-K as Exhibit 8.1. Valiant has reserved up to 12,000,000 shares of
its common stock to issue under grants as part of this plan.
Item 9.01
–
Financial Statements and Exhibits
.
(a) Financial statements of
business acquired.
If required,
financial statements will be filed by amendment to this Form 8-K within
71 days from the date that the filing of this report is required.
(b) Pro forma financial
information.
If required, pro
forma financial information will be filed by amendment to this Form 8-K within
71 days from the date that the filing of this report is required.
(c) Exhibits. The following
exhibits are filed with this Report:
2.1 – Asset
Purchase Agreement, dated April 1, 2009, by and between Valiant
Healthcare, Inc. and Accessible Healthcare Services, Inc.
8.1 – Valiant
Healthcare, Inc. 2009 Stock Incentive Plan
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this Current Report on Form 8-K to be signed on its behalf by the
undersigned hereunto duly authorized.
VALIANT HEALTHCARE, INC.
By:
/s/ Steven Turner
Name: Steven Turner
Title: President
Dated: April 1, 2009
3